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Abstract: A psychiatric involvement is frequently present in Wilson’s disease. Psychiatric symptoms are sometimes the 
first and only manifestation of Wilson’s disease. More often a psychiatric involvement is present beside a neurologic or 
hepatic disease. 
We describe the case of a 18 years-old male patient who shows a clinic and laboratoristic pattern of cirrhosis and an  
history of subchronic hallucinatory psychosis, behavioral symptoms and mood disturbances with depressed mood. He 
hadn’t familiar history of liver or psychiatric disease. Laboratory and imaging tests confirmed the diagnosis of Wilson’s 
disease with psichiatric involvement. After liver transplantation copper metabolism and liver function normalised and we 
noticed no recurrency of the psichiatric illness. Very few cases of psychiatric improvement after orthotopic liver   
transplantation (OLT) has been described until now. 
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INTRODUCTION 
Wilson’s disease (WD), or hepatolenticular degeneration 
[1], is an autosomal recessive disorder caused by the muta-
tion of the ATPase7B gene [2]. The role of the ATPase7B is 
the ATP-dependent escretion of copper into the biliary sys-
tem [3]. The effect of copper accumulation in the liver leads 
to acute liver failure, chronic hepatitis or liver cirrhosis [4], 
while the overload of copper can generate both neurological 
and psychiatric involvement [5]. 
Accumulation of copper in the cytoplasm of hepatocytes 
results in cellular necrosis and leakage of copper into the 
plasma. The excess copper then collects in extrahepatic tis-
sues, including the basal ganglia and the limbus of the cor-
nea.ATP7B transports copper into the secretory pathway of 
the cell for incorporation into the cuproenzymes and excre-
tion from the cell. An increase in the intracellular copper 
level causes ATP7B to move to a cytoplasmic vesicular 
compartment. As the copper is concentrated into vesicles for 
excretion from the cell, the cytosolic copper concentration 
decreases, and ATP7B returns to the trans-Golgi network. 
The movement of ATP7B appears to involve amino acid 
sequences in its carboxyl terminus. The copper concentration 
is higher in brains of people with Wilson disease than in 
other people or animals with diseases of copper over-
load.Wilson himself referred to a “mental change”, whose 
“importance should not be understimate” [1]. From 30% to 
100% of symptomatic patients with WD suffer from psychi-
atric symptoms. From 10% to 20% of patients present   
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psychiatric disorders from 1 to 5 years before the diagnosis 
of WD and one third of this patients receive psychiatric 
treatment, including hospitalization [6]. The most frequent 
psychiatric symptoms in WD are personality changes such as 
irritability and low threshold to anger, depression sometimes 
leading to suicidal ideation and attempts, deteriorating aca-
demic and work performance that is present in almost all 
neurologically affected patients [7]. Anxiety, behavioral ab-
normalities, cognitive impairment have also been described 
[8]. Psychiatric symptoms in WD usually showed a limited 
response to neuroleptic medication or other psychiatric drugs 
[9]. In other cases psychiatric symptoms improved after 
penicillamine treatment [5, 10, 11]. The improvement was 
noticed after 1 or 2 years of treatment [5]. Few cases of psy-
chiatric WD who underwent OLT have been described: in 
one case behavioural and personality disorders were com-
pletely unaffected after transplantation [20]. We describe the 
case of a 18-year-old patient with complete normalization of 
copper and ceruloplasmine levels and efficacy of OLT on 
psychiatric abnormalities. 
MATERIALS AND METHODOLOGY 
A 18-year-old boy was referred to Our Institute in Febru-
ary, 1992. Few months before he suffered from severe asthe-
nia, fever (38-39° C), vomiting, diarrhea and pain referred to 
right hypochondrium. Examination showed gynaecomastia, 
pitting oedema and hepatosplenomegaly.  
During hospitalization he had hallucination and pho-
neme. No neurological deficit was noted. 
Laboratory investigations showed platelets 45.000/mm3, 
aspartate aminotransferase (AST) 106 IU/L, alanine 
aminotransferase (ALT) 107 IU/L, -glutamyl-tranferase 
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2165 U/l. Hepatitis virus serology, TORCH, Monotest, Wi-
dal-Wright, Weil-Felix, Tine test, alpha1-antitrypsin assay 
and autoimmunity tests were negative. Serum ceruloplasmin 
level was 16 mg/dl, serum copper concentration 45 mcg/dl, 
urinary copper concentration/24 h after 600 mg of D-
penicillamine [12] 303 mcg/24h.  
Ultrasound scanning showed a cirrhotic liver with dif-
fusely disomogeneous ultrasonografic structure, sple-
nomegaly with omogeneous ultrasound structure. 
EGDS revealed oesophageal varices (F3). 
Liver biopsy detected architectural abnormalities with 
chronic hepatitis with high grading and bridging fibrosis; the 
staging was III-IV sec. Desmet [13]. Liver copper content 
was 255 mcg/g dry weight. 
The values of the copper balance and liver biopsy were 
diagnostic of Wilson’s disease. 
A psychiatric consultation was arranged and was found a 
Psychotic Disorder Due To Wilson’s Disease (American 
Psychiatric Association. DSM IV TR ed.APA Washington 
DC 1994). The clinical picture presented auditory, somatic 
and formed visual allucinations (as “zoopsias”) and persecu-
tory delusions. Insomnia, asthenia, anorexia, depressed mood 
and social isolation were associated. 
In order to evaluate the involvement of the CNS the pa-
tient underwent slit lamp examination, that was negative for 
the presence of Kayser-Fleisher’s ring. Magnetic resonance 
imaging (MRI) brain scan was normal. The clinical picture, 
results of laboratory examination and liver copper content 
however suggested Wilson’s disease. 
The patient reached endstage liver disease and required a 
transplant; therefore d-penicillamine treatment was not at-
tempted.  
RESULTS 
The patient underwent OLT in July 1993 (“S.Giovanni 
Battista” Hospital, Torino) and after operation we observed a 
sudden improvement of liver function and copper escretion. 
Laboratory investigations demonstrated platelets 
284.000/mm3, aspartate aminotransferase (AST) 27 U.I./l, 
alanine aminotransferase (ALT) 21 U.I./l, International 
Normalised Ratio 1.3 INR, PChE 8660 U/l. Serum ceru-
loplasmin level rised to 39 mg/dl, serum copper concentra-
tion 89.47 mcg/dl, basal urinary copper (17.4 μg/24 h); only 
urinary copper concentration/24 h after challenge of D-
penicillamine was still high (360 mcg/24h) Moreover the 
transplant resolved any psychiatric disfunction. We observe 
this regression until now, twelve years after the transplan-
tion. 
After the operation MRI brain scan was still normal and 
Kayser-Fleisher’s ring was absent again. Evoked potentials 
(somatosensory, visual and brainstem auditory EPs: SEP, 
VEP, BAEP) proved normal. 
Finally, in february 2009, 99mTc-ECD-SPECT (single 
photon emission tomography) revealed an abnormal distribu-
tion of the drug in the brain, with deficient perfusion of left 
temporal lobe and normal perfusion in the basal ganglia. 
DISCUSSION 
Wilson’s disease is a genetic disorder due to the mutation 
of the ATPase7B, that represents the sole mechanism of 
copper excretion. Mutated ATPase7B fails the incorporation 
of copper in ceruloplasmin that results in the decrease of the 
holoceruloplasmine synthesis with low ceruloplasmin serum 
level in affected patients. Progressive copper accumulation 
in the liver causes an oxidative damage that leads to acute or 
chronic hepatitis, asymptomatic cirrhosis or acute liver fail-
ure [14]. In young adults neuropsychiatric symptoms pre-
dominate and are associated, in 90% of cases, with Kayser-
Fleisher’s ring [15].  
Psychiatric symptoms are often the first and unique 
manifestation of the disease, particularly in adolescents and 
young-adults; this can bring to futile psychiatric treatments 
[16] and delay the diagnosis from 1 to 5 years [4].  
More frequently psychiatric disease is associated with 
hepatic and/or neurologic involvement. 
The most frequent psychiatric symptom is depression [7]. 
Depression seems to be correlated with alterations of sero-
toninergic trasmission in the thalamus-hypotalami and mid-
brain-pons region, in particular with low density of the pre-
synaptic serotonin transporter (SERT) [5]. This alterations 
could be related also with psychotic symptoms; in fact it is 
well known that in schizophrenic psychosis there is an al-
teration of serotoninergic transmission [17].  
Emotional lability, lack of appropriate emotions, person-
ality changes, increased or reduced sexual interest, cognitive 
impairment, schizofrenia, nervous anorexia [18] and catato-
nia [19] have also been described [4].  
Our patient suffered from severe liver disease (cirrhosis 
Child Pugh B7) with severe psichiatric involvement. The 
patient didn’t suffer from neurologic symptoms; neurological 
examination and MRI brain scan were normal. 
The treatment of WD consist of copper-chelating agents 
such as penicillamine [20]. Zinc sulphate or acetate inhibit 
intestinal copper absorption and had produced succesfull 
results in patient with neurologic disease [21]. Zinc sulphate 
therapy is more indicate than penicillamine therapy because 
penicillamine can determine a massive dismission of copper 
into circulation with acute worsening of clinic conditions. 
On the other hand it is not yet clear which is the best 
therapy in patients with psychiatric involvement. In such 
cases penicillamine or zinc sulphate has been usefull for 
psychiatric symptoms [22], without any employment of neu-
roleptic medications [4]. In other cases psychiatric drugs 
determined a decline of psychiatric situation [23]. 
In this case the patient didn’t assume any medical therapy 
because he presented the indication for a sudden liver tran-
plantation for decompensated cirrhosis accompanying the 
psychiatric illness. The sole risolutive therapy for WD is 
liver transplantation that normalises liver function and cor-
rect the metabolic defect of copper escretion [24]. 
After transplantation we observed the normalisation of 
liver function, of copper metabolism and of psychiatric 
symptoms. Only urinary copper concentration/24h after 
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value of urinary copper escretion indicate a persistent copper 
overload in extrahepatic tissues. In considering high postop-
erative urinary copper leves, we suggest not to discontinuate 
medical therapy after OLT. 
In the post-operative the patient underwent again brain 
MRI, ECD-SPECT and evoked potentials (EPs) for neuro-
logical evaluation. MRI brain scan and EPs were normal, 
while the SPECT showed an asimmetric distribution of the 
drug. Several studies demonstrate that ECD-SPECT is the 
most sensitive neuroimagine procedure in the monitoring of 
the disease, also in patients without neurological symptoms. 
In one study there was a particular frequency (86%) of dif-
fused or focal decrease of ECD uptake [25]. Also in our pa-
tient we observed a deficit of perfusion in the left temporal 
lobe, though MRI and EPs were normal. 
In the late postoperative (twelve years after the opera-
tion) liver functional values were stil normal and no more 
psychiatric abnormalities were observed.  
As an hypothesys, we suppose that our patient didn’t 
have relapses because he underwent liver trasplant in an 
early fase of the psychiatric disease: infact MRI before the 
transplant showed normal images. Unfortunately in 1994 we 
didn’t dispose of the SPECT. If confirmed in other studies 
this hypothesis could suggest the importance of early treat-
ment. 
Literature offers scarse and discordant data regarding the 
curative effects of OLT under psychiatric aspects. It has been 
described both the curative effect of the transplant on neu-
ropsichiatric symptoms [26] and the severe worsening of 
psychiatric illness [27]. In conclusion from our study emerge 
some prospectives of resolution also of psychiatric disease 
accompained by late-postoperative persistent improvement, 
especially in case of early treatment. 
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